Familial hypercholesterolemia in Morocco: First report of mutations in the LDL receptor gene

Journal of Human Genetics

Volumn 48, Issue 4, 2003, Pages 199-203

  El Messal, Mariame ^a   Aït Chihab, Karima ^b   Chater, Rachid ^b   Vallvé, Joan Carles ^c   Bennis, Faïza ^a   Hafidi, Aïcha ^d   Ribalta, Josep ^c   Varret, Mathilde ^e   Loutfi, Mohammed ^a   Rabès, Jean Pierre ^e,f   Kettani, Anass ^b   Boileau, Catherine ^e,f   Masana, Luis ^c   Adlouni, Ahmed ^b  

^a FACULTÉ DES SCIENCES AIN CHOCK   (Morocco)

^b FACULTÉ DES SCIENCES BEN M SIK   (Morocco)

^c UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^d IBN SINA HOSPITAL   (Morocco)

^e HÔPITAL NECKER ENFANTS MALADES   (France)

^f HÔPITAL AMBROISE PARÉ   (France)

Author keywords

Apolipoprotein B gene; DNA sequencing; Familial hypercholesterolemia; Low density lipoprotein receptor gene; Morocco; Single strand conformation polymorphism; Southern blot

Indexed keywords

APOLIPOPROTEIN B; DNA; LOW DENSITY LIPOPROTEIN RECEPTOR;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; DNA SEQUENCE; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENE AMPLIFICATION; GENE MUTATION; HUMAN; LIPID BLOOD LEVEL; MALE; MOROCCO; PATHOGENESIS; SCHOOL CHILD; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; SOUTHERN BLOTTING;

ADOLESCENT; ADULT; CHILD; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MALE; MIDDLE AGED; MOROCCO; MUTATION; RECEPTORS, LDL;

EID: 0037908684     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10038-003-0010-x     Document Type: Article

References (26)

1. Fisher E, Scharnagl H, Hoffmann MM, et al. (1999) Mutations in the apolipoprotein (apo) B-100 receptor-binding region: detection of apo B-100 (Arg3500CPÆTrp) associated with two new haplotype and evidence that apo B-100 (Glu3405CPÆGln) diminishes receptor-mediated uptake of LDL. Clin Chem 45:1026-1038
2. Fouchier SW, Defesche JC, Umans-Eckenhausen MA, Kastelein JJ (2001) The molecular basis of hypercholesterolemia in the Netherlands. Hum Genet 109:602-615
3. Friedewald WT, Levy FI, Fredrickson DS (1972) Estimation of the concentration of the low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 18:499-509
4. Gaffney D, Reid JM, Cameron IM, Vass K, Caslake M, Sheperd J, Packard CJ (1995) Independent mutations at codon 3500 of the apolipoprotein B gene are associated with hyperlipidaemia. Arterioscler Thromb Vasc 15:1025-1029
5. Goldstein JL, Hobbs HH, Brown MS (1995) Familial hypercholesterolemia. In: Scriver CR, Beaudet AL, Sly W, Valle D (eds) The metabolic and molecular bases of inherited disease, 7th edn. McGraw-Hill, New York, pp 1981-2030
6. Gudnason V, Patel D, Sun X-M, Humphries S, Soutar AK, Knight BL (1995) Effect of the StuI polymorphism in the LDL receptor gene (Ala370 to Thr) on lipid levels in healthy individuals. Clin Genet 47:68-74
7. Haddad L, Day IN, Hunt S, Williams RR, Humphries SE, Hopkins PN (1999) LDLR, non-APOB kindred. J Lipid Res 40:1113-1122
8. Heath KE, Gahan M, Whittal RA, Humphries SE (2001) Low-density lipoprotein receptor gene (LDLR) world-wide web site in familial hypercholesterolemia: update, new features and mutation analysis. Atherosclerosis 154:243-246
9. Hobbs H, Brown MS, Goldstein JL (1992) Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum Mutat 1:4445-4466
10. Humphries SE, Gudnason V, Whittall R (1997) Single-strand conformation polymorphism analysis with high throughput modifications, and its use in mutation detection in familial hypercholesterolemia. Clin Chem 43:427-435
11. Hunt SC, Hopkins PN, Bulka K, McDermott MT, Thorne TL, Wardell BB, Bowen BR, Ballinger DG, Skolnick MH, Samuels ME (2000) Genetic localization to chromosome 1p32 of the third locus for familial hypercholesterolemia in Utah kindred. Arterioscler Thromb Vasc Biol 20:1089-1093
12. Jensen HK, Jensen LG, Hansen PS, Faergeman O, Gregersen N (1996) High sensitivity of the single-strand conformation polymorphism method for detection of sequence variations in the LDL receptor gene validated by DNA sequence. Clin Chem 42:1140-1146
13. Leren TP, Tonstad S, Gudersen KE, Bakken KS, Rodningen OK, Sundvold H, Ose L, Berg K (1997) Molecular genetics of familial hypercholesterolemia in Norway. J Intern Med 241: 185-194
14. Lestavel S, Fruchart JC (1994) Lipoprotein receptors. Cell Mol Biol 40:461-481
15. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from nucleated cells. Nucleic Acids Res 16:1215
16. Myant NB (1993) Familial defective apolipoprotein B-100: a review, including some comparisons with familial hypercholesterolemia. Atherosclerosis 104:1-18
17. Nauck MS, Köster W, Dörfer K, Eckes J, Scharnagl H, Gierens H, Nissen H, Nauck MA, Wieland H, MCPñrz W (2001) Identification of recurrent and novel mutations in the LDL receptor gene in German patients with familial hypercholesterolemia. Hum Mutat 18:165-166
18. Norman D, Sun XM, Bourbon M, Knight BL, Naoumova RP, Soutar AK (1999) Characterization of a novel cellular defect in patients with phenotypic homozygous familial hypercholesterolemia. J Clin Invest 104:619-628
19. Pullinger CR, Hennessy LK, Chatterton JE, Liu W, Love JA, Mendel CM, Frost PH, Malloy MJ, Schumaker VN, Kane JP (1995) FDB: identification of a new mutation that decrease LDL-receptor binding affinity. J Clin Invest 95:1225-1234
20. Rabès JP, Varret M, Saint-Jore B, Erlich D, Jondeau G, Giraudet P, Junien C, Boileau C (1997) Familial ligand-defective apolipoprotein B-100: simultaneous detection of the Arg3500CPÆGln and Arg3531CPÆCys mutations in a French population. Hum Mut 10:160-163
21. Soria LF, Ludwig EH, Clarke HRG, Vega GL, Grundy SM, McCarty BJ (1989) Association between a specific apo B mutation and familial defective apoB100. Proc Natl Acad Sci U S A 86:587-591
22. Soutar AK, Knight BL, Patel DD (1989) Identification of a point mutation in growth factor receptor C of the low density lipoprotein-receptor gene in a patient with homozygous familial hypercholesterolemia that affects ligand binding and intracellular movement of receptors. Proc Natl Acad Sci U S A 86:4166-4170
23. Varret M, Rabès JP, Kotze MJ, Baron H, Cenarro A, Descamps O, Ebhardt M, Nondelijn JC, Kostner GM, Miyake Y, Pocovi M, Shmidt H, Schuster H, Stuhrmann M, Yamamura T, Junien C, Beroud C, Boileau C (1998) LDLR database (second edition): new additions to the database and the software, and results of the first molecular analysis. Nucleic Acids Res 26:248-252
24. Varret M, Rabès JP, Saint-Jore B, Cenarro A, Marinoni JC, Civeira F, Devillers M, Krempf, Culon M, Thiart R, Kotze MJ, Schmidt H, Buzzi JC, Kostner GM, Bertoleni S, Rosa A, farnier M, Martinez M, Junien C, Boileau C (1999) A third major locus for autosomal dominant hypercholesterolemia maps to 1p34.1-32. Am J Human Gene 64:1378-1387
25. Weiss N, Binder G, Keller C (1998) Heterozygosity for the missense mutation Ala370CPÆThr in exon 8 of the low density lipoprotein receptor gene does not cause hypercholesterolemia. Eur J Med Res 3:20-24
26. Yamamoto T, Davis CG, Brown MS, Schneider WJ, Casey ML, Goldstein JL, Russell DW (1984) The human LDL receptor: a cysteine-rich protein with multiple Alu sequences in its mRNA. Cell 39:27-38